Anzor Pharmaceuticals CEO to Present Breakthrough Therapy at Chronic Kidney Disease Conference
March 19, 2025 — Anzor Pharmaceuticals CEO presents groundbreaking FGF peptide therapy for chronic kidney disease at conference, offering hope for improved treatments. Learn more about the latest advancements in CKD research and potential impact on patient care.